This Test Guideline describes a Rapid Estrogen ACTivity In Vivo (REACTIV) Assay in an aquatic assay that utilises transgenic Oryzias latipes (Japanese medaka) eleutheroembryos at day post hatch zero, in a multi-well plate format to identify chemicals active on the estrogen axis. The REACTIV assay was designed as a screening assay to provide a medium throughput and short-term assay to measure the response of eleutheroembryos to chemicals potentially active on the estrogen axis.
Test No. 252: Rapid Estrogen Activity In Vivo (REACTIV) assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
25 June 202511 Pages
-
25 June 202522 Pages
-
25 June 202524 Pages
Related publications
-
2 July 2026115 Pages
-
Report2 July 202632 Pages
-
2 July 202615 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
Report
Assays addressing the Adverse Outcome Pathway key event on covalent binding to proteins
2 July 202663 Pages -
Report
Assays addressing the Adverse Outcome Pathway Key Event on Keratinocyte activation
2 July 202698 Pages